Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	245.95B +65.2%
Revenue (ttm)	21.92B +29.4%
Net Income	3.49B +105.1%
EPS	16.43 +90.8%
Shares Out	212.02M
PE Ratio	70.60
Forward PE	60.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	488,291
Open	1,175.00
Previous Close	1,160.00
Day's Range	1,127.10 - 1,175.60
52-Week Range	707.00 - 1,184.80
Beta	n/a
Analysts	Strong Buy
Price Target	1,275.00 (+11.33%)
Earnings Date	May 14, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,401
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In fiscal year 2026, Sai Life Sciences's revenue was 21.92 billion, an increase of 29.38% compared to the previous year's 16.95 billion. Earnings were 3.49 billion, an increase of 105.08%.